Combining EGFR CAR NK cells with oncolytic herpes simplex virus-1 or chemotherapeutics showed synergistic effects on breast cancer and renal cell carcinoma (RCC) in mice, respectively [110,111]. This evidence concerns the gene EGFR and renal cell carcinoma.